FDA Inspection
Novartis d.o.o.Novartis d.o.o. – FDA Inspection, Jul 21, 2023
Record Details
This FDA Inspection record concerns Novartis d.o.o., with an inspection on July 21, 2023, issued by the Office of Inspections and Investigations.
- Company
- Novartis d.o.o.
- Inspection Date
- July 21, 2023
View Company Profile
ID · be1f8dbf-ec85-4afd-ab0b-b5d25b8b0ca7
Inspection Facts
- Inspection number
- 1215215
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Novartis d.o.o.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 19, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novartis d.o.o.
- FDA Inspection 1228827 - 2022-09-21
- FDA Inspection 1155320 - 2020-09-11
- FDA Inspection 1004338 - 2017-02-13
- FDA Inspection 945699 - 2015-09-18
- FDA Inspection 807398 - 2012-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.